Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-trace').style.display = (document.getElementById('cakeErr6817ab28448ed-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6817ab28448ed-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-code').style.display = (document.getElementById('cakeErr6817ab28448ed-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-context').style.display = (document.getElementById('cakeErr6817ab28448ed-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6817ab28448ed-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6817ab28448ed-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 25177,
		&#039;title&#039; =&gt; &#039;Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of these medicines are allowed an annual hike based on Wholesale Price Index
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
For all other medicines, companies are free to raise prices up to 10 per cent annually
&lt;/div&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 23 June, 2014, http://www.business-standard.com/article/companies/pharma-pricing-norms-set-to-be-tightened-114062300010_1.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4673211,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 25177,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Business Standard


&amp;nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of these medicines are allowed an annual hike based on Wholesale Price Index&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;For all other medicines, companies are free to raise prices up to 10 per cent annually&lt;/div&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 25177,
	&#039;title&#039; =&gt; &#039;Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of these medicines are allowed an annual hike based on Wholesale Price Index
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
For all other medicines, companies are free to raise prices up to 10 per cent annually
&lt;/div&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 23 June, 2014, http://www.business-standard.com/article/companies/pharma-pricing-norms-set-to-be-tightened-114062300010_1.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4673211,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 25177
$metaTitle = &#039;LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Business Standard


&amp;nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of these medicines are allowed an annual hike based on Wholesale Price Index&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;For all other medicines, companies are free to raise prices up to 10 per cent annually&lt;/div&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Business Standard


&nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pharma pricing norms set to be tightened -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Business Standard</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>Regulator studying pricing models in various nations; draft legislation likely by end of March</em></p><p style="text-align: justify">Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.</p><p style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.</p><p style="text-align: justify">&quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months' time we will formally commission the study,&quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.</p><p style="text-align: justify">At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.</p><p style="text-align: justify">The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.</p><p style="text-align: justify">&quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&quot; Srinivas said.</p><p style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.</p><p style="text-align: justify">While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.</p><p style="text-align: justify">In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.</p><p>&nbsp;</p><div style="text-align: justify"><strong>PRICE CONTROL MECHANISM</strong></div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation</div><div style="text-align: justify">Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share</div><div style="text-align: justify">Prices of these medicines are allowed an annual hike based on Wholesale Price Index</div><div style="text-align: justify">For all other medicines, companies are free to raise prices up to 10 per cent annually</div><p>&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-trace').style.display = (document.getElementById('cakeErr6817ab28448ed-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6817ab28448ed-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-code').style.display = (document.getElementById('cakeErr6817ab28448ed-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-context').style.display = (document.getElementById('cakeErr6817ab28448ed-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6817ab28448ed-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6817ab28448ed-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 25177,
		&#039;title&#039; =&gt; &#039;Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of these medicines are allowed an annual hike based on Wholesale Price Index
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
For all other medicines, companies are free to raise prices up to 10 per cent annually
&lt;/div&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 23 June, 2014, http://www.business-standard.com/article/companies/pharma-pricing-norms-set-to-be-tightened-114062300010_1.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4673211,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 25177,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Business Standard


&amp;nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of these medicines are allowed an annual hike based on Wholesale Price Index&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;For all other medicines, companies are free to raise prices up to 10 per cent annually&lt;/div&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 25177,
	&#039;title&#039; =&gt; &#039;Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of these medicines are allowed an annual hike based on Wholesale Price Index
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
For all other medicines, companies are free to raise prices up to 10 per cent annually
&lt;/div&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 23 June, 2014, http://www.business-standard.com/article/companies/pharma-pricing-norms-set-to-be-tightened-114062300010_1.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4673211,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 25177
$metaTitle = &#039;LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Business Standard


&amp;nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of these medicines are allowed an annual hike based on Wholesale Price Index&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;For all other medicines, companies are free to raise prices up to 10 per cent annually&lt;/div&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Business Standard


&nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pharma pricing norms set to be tightened -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Business Standard</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>Regulator studying pricing models in various nations; draft legislation likely by end of March</em></p><p style="text-align: justify">Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.</p><p style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.</p><p style="text-align: justify">&quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months' time we will formally commission the study,&quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.</p><p style="text-align: justify">At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.</p><p style="text-align: justify">The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.</p><p style="text-align: justify">&quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&quot; Srinivas said.</p><p style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.</p><p style="text-align: justify">While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.</p><p style="text-align: justify">In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.</p><p>&nbsp;</p><div style="text-align: justify"><strong>PRICE CONTROL MECHANISM</strong></div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation</div><div style="text-align: justify">Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share</div><div style="text-align: justify">Prices of these medicines are allowed an annual hike based on Wholesale Price Index</div><div style="text-align: justify">For all other medicines, companies are free to raise prices up to 10 per cent annually</div><p>&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-trace').style.display = (document.getElementById('cakeErr6817ab28448ed-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6817ab28448ed-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-code').style.display = (document.getElementById('cakeErr6817ab28448ed-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6817ab28448ed-context').style.display = (document.getElementById('cakeErr6817ab28448ed-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6817ab28448ed-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6817ab28448ed-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 25177,
		&#039;title&#039; =&gt; &#039;Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of these medicines are allowed an annual hike based on Wholesale Price Index
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
For all other medicines, companies are free to raise prices up to 10 per cent annually
&lt;/div&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 23 June, 2014, http://www.business-standard.com/article/companies/pharma-pricing-norms-set-to-be-tightened-114062300010_1.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4673211,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 25177,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Business Standard


&amp;nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of these medicines are allowed an annual hike based on Wholesale Price Index&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;For all other medicines, companies are free to raise prices up to 10 per cent annually&lt;/div&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 25177,
	&#039;title&#039; =&gt; &#039;Pharma pricing norms set to be tightened -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Prices of these medicines are allowed an annual hike based on Wholesale Price Index
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
For all other medicines, companies are free to raise prices up to 10 per cent annually
&lt;/div&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 23 June, 2014, http://www.business-standard.com/article/companies/pharma-pricing-norms-set-to-be-tightened-114062300010_1.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4673211,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 25177
$metaTitle = &#039;LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Business Standard


&amp;nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;Regulator studying pricing models in various nations; draft legislation likely by end of March&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months&#039; time we will formally commission the study,&amp;quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&amp;quot; Srinivas said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;strong&gt;PRICE CONTROL MECHANISM&lt;/strong&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Prices of these medicines are allowed an annual hike based on Wholesale Price Index&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;For all other medicines, companies are free to raise prices up to 10 per cent annually&lt;/div&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Business Standard


&nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pharma pricing norms set to be tightened -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Business Standard</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>Regulator studying pricing models in various nations; draft legislation likely by end of March</em></p><p style="text-align: justify">Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.</p><p style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.</p><p style="text-align: justify">&quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months' time we will formally commission the study,&quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.</p><p style="text-align: justify">At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.</p><p style="text-align: justify">The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.</p><p style="text-align: justify">&quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&quot; Srinivas said.</p><p style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.</p><p style="text-align: justify">While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.</p><p style="text-align: justify">In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.</p><p>&nbsp;</p><div style="text-align: justify"><strong>PRICE CONTROL MECHANISM</strong></div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation</div><div style="text-align: justify">Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share</div><div style="text-align: justify">Prices of these medicines are allowed an annual hike based on Wholesale Price Index</div><div style="text-align: justify">For all other medicines, companies are free to raise prices up to 10 per cent annually</div><p>&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 25177,
		'title' => 'Pharma pricing norms set to be tightened -Sushmi Dey',
		'subheading' => '',
		'description' => '<div style="text-align: justify">
-The Business Standard
</div>
<p style="text-align: justify">
&nbsp;
</p>
<p style="text-align: justify">
<em>Regulator studying pricing models in various nations; draft legislation likely by end of March</em>
</p>
<p style="text-align: justify">
Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.
</p>
<p style="text-align: justify">
The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.
</p>
<p style="text-align: justify">
&quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months' time we will formally commission the study,&quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.
</p>
<p style="text-align: justify">
At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.
</p>
<p style="text-align: justify">
The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.
</p>
<p style="text-align: justify">
&quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&quot; Srinivas said.
</p>
<p style="text-align: justify">
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.
</p>
<p style="text-align: justify">
While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.
</p>
<p style="text-align: justify">
In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.
</p>
<p>
&nbsp;
</p>
<div style="text-align: justify">
<strong>PRICE CONTROL MECHANISM</strong>
</div>
<div style="text-align: justify">
&nbsp;
</div>
<div style="text-align: justify">
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation
</div>
<div style="text-align: justify">
Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share
</div>
<div style="text-align: justify">
Prices of these medicines are allowed an annual hike based on Wholesale Price Index
</div>
<div style="text-align: justify">
For all other medicines, companies are free to raise prices up to 10 per cent annually
</div>
<p>
&nbsp;
</p>',
		'credit_writer' => 'The Business Standard, 23 June, 2014, http://www.business-standard.com/article/companies/pharma-pricing-norms-set-to-be-tightened-114062300010_1.html',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4673211,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 25177,
	'metaTitle' => 'LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey',
	'metaKeywords' => 'medicines,Health',
	'metaDesc' => '
-The Business Standard


&nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models...',
	'disp' => '<div style="text-align: justify">-The Business Standard</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>Regulator studying pricing models in various nations; draft legislation likely by end of March</em></p><p style="text-align: justify">Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.</p><p style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.</p><p style="text-align: justify">&quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months' time we will formally commission the study,&quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.</p><p style="text-align: justify">At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.</p><p style="text-align: justify">The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.</p><p style="text-align: justify">&quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&quot; Srinivas said.</p><p style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.</p><p style="text-align: justify">While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.</p><p style="text-align: justify">In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.</p><p>&nbsp;</p><div style="text-align: justify"><strong>PRICE CONTROL MECHANISM</strong></div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation</div><div style="text-align: justify">Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share</div><div style="text-align: justify">Prices of these medicines are allowed an annual hike based on Wholesale Price Index</div><div style="text-align: justify">For all other medicines, companies are free to raise prices up to 10 per cent annually</div><p>&nbsp;</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 25177,
	'title' => 'Pharma pricing norms set to be tightened -Sushmi Dey',
	'subheading' => '',
	'description' => '<div style="text-align: justify">
-The Business Standard
</div>
<p style="text-align: justify">
&nbsp;
</p>
<p style="text-align: justify">
<em>Regulator studying pricing models in various nations; draft legislation likely by end of March</em>
</p>
<p style="text-align: justify">
Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.
</p>
<p style="text-align: justify">
The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.
</p>
<p style="text-align: justify">
&quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months' time we will formally commission the study,&quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.
</p>
<p style="text-align: justify">
At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.
</p>
<p style="text-align: justify">
The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.
</p>
<p style="text-align: justify">
&quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&quot; Srinivas said.
</p>
<p style="text-align: justify">
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.
</p>
<p style="text-align: justify">
While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.
</p>
<p style="text-align: justify">
In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.
</p>
<p>
&nbsp;
</p>
<div style="text-align: justify">
<strong>PRICE CONTROL MECHANISM</strong>
</div>
<div style="text-align: justify">
&nbsp;
</div>
<div style="text-align: justify">
Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation
</div>
<div style="text-align: justify">
Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share
</div>
<div style="text-align: justify">
Prices of these medicines are allowed an annual hike based on Wholesale Price Index
</div>
<div style="text-align: justify">
For all other medicines, companies are free to raise prices up to 10 per cent annually
</div>
<p>
&nbsp;
</p>',
	'credit_writer' => 'The Business Standard, 23 June, 2014, http://www.business-standard.com/article/companies/pharma-pricing-norms-set-to-be-tightened-114062300010_1.html',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'pharma-pricing-norms-set-to-be-tightened-sushmi-dey-4673211',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4673211,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 25177
$metaTitle = 'LATEST NEWS UPDATES | Pharma pricing norms set to be tightened -Sushmi Dey'
$metaKeywords = 'medicines,Health'
$metaDesc = '
-The Business Standard


&nbsp;


Regulator studying pricing models in various nations; draft legislation likely by end of March


Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models...'
$disp = '<div style="text-align: justify">-The Business Standard</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>Regulator studying pricing models in various nations; draft legislation likely by end of March</em></p><p style="text-align: justify">Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries.</p><p style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year.</p><p style="text-align: justify">&quot;We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months' time we will formally commission the study,&quot; Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs.</p><p style="text-align: justify">At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government.</p><p style="text-align: justify">The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines.</p><p style="text-align: justify">&quot;An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices,&quot; Srinivas said.</p><p style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually.</p><p style="text-align: justify">While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment.</p><p style="text-align: justify">In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.</p><p>&nbsp;</p><div style="text-align: justify"><strong>PRICE CONTROL MECHANISM</strong></div><div style="text-align: justify">&nbsp;</div><div style="text-align: justify">Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation</div><div style="text-align: justify">Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share</div><div style="text-align: justify">Prices of these medicines are allowed an annual hike based on Wholesale Price Index</div><div style="text-align: justify">For all other medicines, companies are free to raise prices up to 10 per cent annually</div><p>&nbsp;</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Pharma pricing norms set to be tightened -Sushmi Dey

-The Business Standard   Regulator studying pricing models in various nations; draft legislation likely by end of March Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries. The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market, has already initiated work in that direction. NPPA Chairman Injeti Srinivas said the agency plans to come up with the first draft of the legislation by the end of this financial year. "We have started dialogue with some institutions to commission a study that would look into pricing models of different countries. We are also internally exploring areas that this study should focus on and terms of reference etc. In two-three months' time we will formally commission the study," Srinivas told Business Standard. He added the proposed legislation will cover all kind of medicines including patented, imported and even non-scheduled drugs. At present, medicine prices are regulated under the Drug Price Control Order (DPCO), 2013, emerging out of the National Pharmaceutical Pricing Policy, which was cleared by the previous government. The proposed legislation would also provide more teeth to NPPA, enabling it to penalise companies flouting the law or overcharging consumers for medicines. "An Act is much superior instrument to merely rule-making power. Our endeavour would be to move towards a progressive legislation based on international models, which will be reasonable while providing more powers to NPPA to keep a check on prices," Srinivas said. Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation, where prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share. Prices of these medicines are allowed an annual hike based on Wholesale Price Index. For all other medicines, companies are free to raise prices up to 10 per cent annually. While the new government at the Centre is expected to keep a stringent check on prices of medicines and make them affordable for the common man, the NPPA, of late, has taken some stringent steps in the direction. For instance, for the first time, the regulator has attempted to cap the launch price of medicines. In a recent notification, the regulator said prices of new brands of existing medicines will have to be at par with the most expensive drug in the segment. In another such notification, using a public interest provision in the DPCO, 2013, the regulator has said it would monitor the difference in prices between various brands of medicines used in treatment of cancer, HIV, tuberculosis, malaria, cardiovascular diseases, diabetes and asthma.   PRICE CONTROL MECHANISM   Currently, around 30 per cent of the total Rs 79,000-crore domestic pharmaceutical market is under regulation Prices of 348 essential medicines are capped at the average of all drugs in a particular segment with more than one per cent market share Prices of these medicines are allowed an annual hike based on Wholesale Price Index For all other medicines, companies are free to raise prices up to 10 per cent annually